Daily Archives: February 14, 2012

Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis

Posted on February 14, 2012 by

Translators: Esparza Olcina MJ1 1Centro de Salud Barcelona. Móstoles. Madrid (España).  Correspondence: María Jesús Esparza Olcina. Email: mjesparza8@gmail.com Publication date: 21/09/2011    Article origen Sitio web del Centre for Reviews and Dissemination (CDR). University of York. Database of Abstracts of Reviews of Effects (DARE). Traducción autorizada. Los autores del … Continue reading →

Posted in ADHD, Centre for Review and Dissemination, children, efficacy, pediatria basada en la evidencia, teenagers, UK, University of York | Leave a comment

FDA sets draft rules for biotech drug copies

Posted on February 14, 2012 by

Image via Wikipedia Via: Linkedin By Deena Beasley Thu Feb 9, 2012 4:46pm EST (Reuters) – The Food and Drug Administration’s long-awaited guidelines for the sale of lower-cost versions of biotechnology drugs leave open the possibility that some products might … Continue reading →

Posted in Amgen, Biogen Idec, Biotechnology, Brian Abrahams, Congressional Budget Office, FDA, Food and Drug Administration, Wells Fargo | Leave a comment